Chapter 5 Rubella Epidemiology: Surveillance to Monitor and Evaluate Congenital Rubella Prevention Strategies

Perspectives in Medical Virology

Volumn 15, Issue , 2006, Pages 95-114

  Peckham, Catherine ^a   Tookey, Pat ^a   Hardelid, Pia ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751281508     PISSN: 01687069     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0168-7069(06)15005-3     Document Type: Review

References (74)

1. Anderson R.M., and Grenfell B.T. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom. J Hyg (Lond) 96 (1986) 305-333
2. Anderson R.M., and May R.M. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) 90 (1983) 259-325
3. Anderson R.M., and May R.M. Infectious Diseases of Humans: Dynamics and Control (1991), Oxford University Press, Oxford
4. Best J., and Banatvala J.E. Rubella. In: Zuckerman A.J., Banatvala J.E., Pattison J.R., Griffiths P.D., and Schoub B.D. (Eds). Principles and Practice of Clinical Virology (2004), Wiley, Chichester
5. Briss P.A., Fehrs L.J., Hutcheson R.H., and Schaffner W. Rubella among the Amish: resurgent disease in a highly susceptible community. Pediatr Infect Dis J 11 (1992) 955-959
6. Castillo-Solorzano C., Carrasco P., Tambini G., Reef S., Brana M., and de Quadros C.A. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis 187 Suppl 1 (2003) S146-S152
7. Celers J., Aymard M., Feingold J., and Godde-Jolly D. [Rubella and congenital cataracts]. Arch Fr Pediatr 40 (1983) 391-395
8. Cheffins T., Chan A., Keane R.J., Haan E.A., and Hall R. The impact of rubella immunisation on the incidence of rubella, congenital rubella syndrome and rubella-related terminations of pregnancy in South Australia. Br J Obstet Gynaecol 105 (1998) 998-1004
9. Christenson B., and Bottiger M. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults. Vaccine 12 (1994) 41-45
10. Cooper L.Z., and Alford C.A. Rubella. In: Remington J.S., and Klein J.O. (Eds). Infectious Diseases of the Fetus and the Newborn Infant (2001), W.B. Saunders Company, Philadelphia 347-388
11. Cutts F.T., Abebe A., Messele T., Dejene A., Enquselassie F., Nigatu W., et al. Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia. Epidemiol Infect 124 (2000) 467-479
12. Cutts F.T., Best J., Siqueira M.M., Engstrom K., and Robertson S.E. Guidelines for Surveillance of Congenital Rubella Syndrome (CRS) and Rubella (1999), World Health Organisation, Department of Vaccines and Other Biologicals, Geneva
13. Cutts F.T., Robertson S.E., Diaz-Ortega J.L., and Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: burden of disease from CRS. Bull World Health Organ 75 (1997) 55-68
14. Cutts F.T., and Vynnycky E. Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol 28 (1999) 1176-1184
15. Davidkin I., Peltola H., and Leinikki P. Epidemiology of rubella in Finland. Euro Surveill 9 (2004) 13-14
16. Davidkin I., Peltola H., Leinikki P., and Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine 18 (2000) 3106-3112
17. de Haas R., van den H.S., Berbers G.A., de Melker H.E., and Conyn-van Spaendonck M.A. Prevalence of antibodies against rubella virus in the Netherlands 9 years after changing from selective to mass vaccination. Epidemiol Infect 123 (1999) 263-270
18. de Melker H.E., van den H.S., Berbers G.A., and Conyn-van Spaendonck M.A. Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b. Vaccine 21 (2003) 716-720
19. Eckstein M.B., Brown D.W., Foster A., Richards A.F., Gilbert C.E., and Vijayalakshmi P. Congenital rubella in south India: diagnosis using saliva from infants with cataract. BMJ 312 (1996) 161
20. Enders G., Nickerl-Pacher U., Miller E., and Cradock-Watson J.E. Outcome of confirmed periconceptional maternal rubella. Lancet 1 (1988) 1445-1447
21. EPI Newsletter. Brazil accelerates control of rubella and prevention of congenital rubella syndrome. EPI Newsl 24 (2002) 1-3
22. Forrest J.M., Menser M.A., and Burgess J.A. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 2 (1971) 332-334
23. Forrest J.M., Turnbull F.M., Sholler G.F., Hawker R.E., Martin F.J., Doran T.T., et al. Gregg's congenital rubella patients 60 years later. Med J Aust 177 (2002) 664-667
24. Giannakos G., Pirounaki M., and Hadjichristodoulou C. Incidence of congenital rubella in Greece has decreased. BMJ 320 (2000) 1408
25. Grillner L., Forsgren M., Barr B., Bottiger M., Danielsson L., and De Verdier C. Outcome of rubella during pregnancy with special reference to the 17th-24th weeks of gestation. Scand J Infect Dis 15 (1983) 321-325
26. Gunasekera D.P., and Gunasekera P.C. Rubella immunisation-learning from developed countries. Lancet 347 (1996) 1694-1695
27. Gupta R.K., Best J., and MacMahon E. Mumps and the UK epidemic 2005. BMJ 330 (2005) 1132-1135
28. Hanratty B., Holt T., Duffell E., Patterson W., Ramsay M., White J.M., et al. UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe. Epidemiol Infect 125 (2000) 377-383
29. Health Protection Agency. Increase in measles cases in 2006, in England and Wales. CDR Wkly 16 (2006) 3
30. HMSO. Immunisation against Infectious Disease (1996), HMSO, Department of Health, London
31. Hofmann J., Kortung M., Pustowoit B., Faber R., Piskazeck U., and Liebert U.G. Persistent fetal rubella vaccine virus infection following inadvertent vaccination during early pregnancy. J Med Virol 61 (2000) 155-158
32. Jansen V.A., Stollenwerk N., Jensen H.J., Ramsay M.E., Edmunds W.J., and Rhodes C.J. Measles outbreaks in a population with declining vaccine uptake. Science 301 (2003) 804
33. Knox E.G. Theoretical aspects of rubella vaccination strategies. Rev Infect Dis 7 Suppl 1 (1985) S194-S197
34. Marshall W.C. The clinical impact of intrauterine rubella. Ciba Found Symp 10 (1972) 3-22
35. Massad E., Azevedo-Neto R.S., Burattini M.N., Zanetta D.M., Coutinho F.A., Yang H.M., et al. Assessing the efficacy of a mixed vaccination strategy against rubella in Sao Paulo, Brazil. Int J Epidemiol 24 (1995) 842-850
36. McBrien J., Murphy J., Gill D., Cronin M., O'Donovan C., and Cafferkey M.T. Measles outbreak in Dublin, 2000. Pediatr Infect Dis J 22 (2003) 580-584
37. McIntosh E.D., and Menser M.A. A fifty-year follow-up of congenital rubella. Lancet 340 (1992) 414-415
38. Mellinger A.K., Cragan J.D., Atkinson W.L., Williams W.W., Kleger B., Kimber R.G., et al. High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr Infect Dis J 14 (1995) 573-578
39. Menser M.A., Dods L., and Harley J.D. A twenty-five-year follow-up of congenital rubella. Lancet 2 (1967) 1347-1350
40. Menser M.A., Forrest J.M., and Bransby R.D. Rubella infection and diabetes mellitus. Lancet 1 (1978) 57-60
41. Miller C.L. Rubella in the developing world. Epidemiol Infect 107 (1991) 63-68
42. Miller E. Rubella reinfection. Arch. Dis Child 65 (1990) 820-821
43. Miller E. Rubella in the United Kingdom. Epidemiol Infect 107 (1991) 31-42
44. Miller E., Cradock-Watson J.E., and Pollock T.M. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 2 (1982) 781-784
45. Miller E., Waight P., Gay N., Ramsay M., Vurdien J., Morgan-Capner P., et al. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev 7 (1997) R26-R32
46. Miller E., Waight P.A., Vurdien J.E., White J.M., Jones G., Miller B.H., et al. Rubella surveillance to December 1990: a joint report from the PHLS and National Congenital Rubella Surveillance Programme. CDR (Lond Engl Rev) 1 (1991) R33-R37
47. MMWR Morbidity Mortality Weekly Report. Elimination of rubella and congenital rubella syndrome-United States, 1969-2004. MMWR Morb Mortal Wkly Rep 54 (2005) 279-282
48. Morgan-Capner P., Miller E., Vurdien J.E., and Ramsay M.E. Outcome of pregnancy after maternal reinfection with rubella. CDR (Lond Engl Rev) 1 (1991) R57-R59
49. NHS Health and Social Care Information Centre. NHS Immunisation Statistics, England: 2004-05, Department of Health; 2005.
50. Nicoll A., Lynn R., Rahi J., Verity C., and Haines L. Public health outputs from the British Paediatric Surveillance Unit and similar clinician-based systems. J R Soc Med 93 (2000) 580-585
51. Nokes D.J., and Anderson R.M. Measles, mumps, and rubella vaccine: what coverage to block transmission?. Lancet 2 (1988) 1374
52. Panagiotopoulos T., Antoniadou I., and Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. BMJ 319 (1999) 1462-1467
53. Panagiotopoulos T., and Georgakopoulou T. Epidemiology of rubella and congenital rubella syndrome in Greece, 1994-2003. Euro Surveill 9 (2004) 17-19
54. Peckham C. Congenital rubella in the United Kingdom before 1970: the prevaccine era. Rev Infect Dis 7 Suppl 1 (1985) S11-S16
55. Peckham C.S. Clinical and laboratory study of children exposed in utero to maternal rubella. Arch Dis Child 47 (1972) 571-577
56. Peckham C.S., Martin J.A., Marshall W.C., and Dudgeon J.A. Congenital rubella deafness: a preventable disease. Lancet 1 (1979) 258-261
57. Rafila A., Marin M., Pistol A., Nicolaiciuc D., Lupulescu E., Uzicanin A., et al. A large rubella outbreak, Romania-2003. Euro Surveill 9 (2004) 7-9
58. Reef S.E., Frey T.K., Theall K., Abernathy E., Burnett C.L., Icenogle J., et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA 287 (2002) 464-472
59. Reef S.E., Plotkin S., Cordero J.F., Katz M., Cooper L., Schwartz B., et al. Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis 31 (2000) 85-95
60. Robertson S.E., Cutts F.T., Samuel R., and Diaz-Ortega J.L. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: vaccination against rubella. Bull World Health Organ 75 (1997) 69-80
61. Sullivan E.M., Burgess M.A., and Forrest J.M. The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997. Commun Dis Intell 23 (1999) 209-214
62. Tookey P. Pregnancy is contraindication for rubella vaccination still. BMJ 322 (2001) 1489
63. Tookey P. Rubella in England, Scotland and Wales. Euro Surveill 9 (2004) 21-22
64. Tookey P., Molyneaux P., and Helms P. UK case of congenital rubella can be linked to Greek cases. BMJ 321 (2000) 766-767
65. Tookey P.A., Cortina-Borja M., and Peckham C.S. Rubella susceptibility among pregnant women in North London, 1996-1999. J Public Health Med 24 (2002) 211-216
66. Tookey P.A., and Peckham C.S. Surveillance of congenital rubella in Great Britain, 1971-96. BMJ 318 (1999) 769-770
67. Ushida M., Katow S., and Furukawa S. Congenital rubella syndrome due to infection after maternal antibody conversion with vaccine. Jpn J Infect Dis 56 (2003) 68-69
68. van der Veen Y., Hahne S., Ruijs H., van Binnendijk R., Timen A., van Loon A., et al. Rubella outbreak in an unvaccinated religious community in the Netherlands leads to cases of congenital rubella syndrome. Euro Surveill 10 (2005) 274-275
69. Vynnycky E., Gay N.J., and Cutts F.T. The predicted impact of private sector MMR vaccination on the burden of congenital rubella syndrome. Vaccine 21 (2003) 2708-2719
70. Weekly Epidemiological Record. Progress towards elimination of measles and prevention of congenital rubella infection in the WHO European Region, 1990-2004. Wkly Epidemiol Rec 80 (2005) 66-71
71. World Health Organisation, Department of Vaccines and Biologicals. Report of a Meeting on Preventing Congenital Rubella Syndrome: Immunization Strategies, Surveillance Needs. Geneva: World Health Organisation; 2000.
72. World Health Organisation. Surveillance Guidelines for Measles and Congenital Rubella Infection in the WHO European Region (2003), WHO, Europe, Copenhagen
73. th May 2006. (Electronic Citation).
74. Zgorniak-Nowosielska I., Zawilinska B., and Szostek S. Rubella infection during pregnancy in the 1985-86 epidemic: follow-up after seven years. Eur J Epidemiol 12 (1996) 303-308